# Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)

> **NCT03967964** · PHASE1 · COMPLETED · sponsor: **Laboratorios Andromaco S.A.** · enrollment: 46 (actual)

## Conditions studied

- Pharmacokinetics
- Hormone Deficiency

## Interventions

- **DRUG:** Dehydroepiandrosterone 2.2 g
- **DRUG:** Dehydroepiandrosterone 1.5 g/Testosterone 25 mg
- **DRUG:** Testosterone
- **DRUG:** Testosterone Topical Gel
- **DRUG:** Dehydroepiandrosterone Oral Capsule

## Key facts

- **NCT ID:** NCT03967964
- **Lead sponsor:** Laboratorios Andromaco S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-20
- **Primary completion:** 2016-07-15
- **Final completion:** 2016-07-15
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03967964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03967964, "Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03967964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*